Evaluation of glutathione localization in brain using 99mTc meso- HMPAO

Journal of Nuclear Medicine

Volumn 40, Issue 6, 1999, Pages 1056-1060

  Sasaki, Toru ^a   Senda, Michio ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

99mTc meso hexamethyl propyleneamine oxime; Brain; Glutathione; Histochemical evaluation; Regional distribution

Indexed keywords

GLUTATHIONE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MALEIC ACID DIETHYL ESTER;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; FOREBRAIN; GRAY MATTER; HIPPOCAMPUS; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION; WHITE MATTER;

ANIMALS; AUTORADIOGRAPHY; BRAIN; BRAIN STEM; CEREBELLUM; CEREBRAL CORTEX; GLUTATHIONE; HIPPOCAMPUS; HISTOCYTOCHEMISTRY; MICE; PROSENCEPHALON; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0033064113     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sasaki T, Toyama H, Oda K, et al. Assessment of antioxidalive ability in brain: technetium-99m meso-hexamethyl propyleneamine oxime as an imaging agent for glutathione localization. J Nucl Med. 1996;37:1698-1701.
2. Ballinger JR, Reid RH, Gulenchyn KY. Technetium-99m HMPAO stereoisomers: differences in interaction with glutathione. J Nucl Med. 1988;29:1998-2000.
3. Neirinckx RD, Burke JF, Harrison RC, et al. The retention mechanism of technetium-99m-HMPAO: intracellular reaction with glutathione. J Cereb Blood Flow Metab. 1988;8:S4-S12.
4. Sasaki T, Senda M. Technetium-99m mesohexamethyl propyleneamine oxime as a potential agent for imaging cerebral glutathione content. J Nucl Med. 1997;38: 1125-1129.
5. Asghar K, Reddy BG, Krishna G. Histochemical localization of glutathione in tissues. J Histochem Cytochem. 1975;774-779.
6. Slivka A, Mytilineou C, Cohen G. Histochemical evaluation of glutathione in brain. Brain Res. 1987;409:275-284.
7. Pearce RKB, Owen A, Daniel S, et al. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J Neural Transm. 1997;104:661-677.
8. Mizui T, Kinouchi H, Chan PH. Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats. Am J Physiol. 1992;262: H313-H317.
9. Perry T, Godin DV, Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett. 1982;33:305-310.
10. Perry T, Yong VW. Idiopathic parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patient. Neurosci Lett. 1986;67:269-274.
11. Slivka A, Spina MB, Cohen G. Reduced and oxidized glutalhione in human and monkey brain. Neuroscience Lett. 1987;74:112-118.
12. Ravindranath V, Shivakumar BR, Anandatheerrthavarada HK. Low glutathione levels in brain regions of aged rats. Neurosci Lett. 1989;101:187-190.
13. Kume-Kick J, Ferris DC, Russo-Menna I, et al. Enhanced oxidative stress in female rat brain after gonadectomy. Brain Res. 1996;738:8-14.
14. Somani SM, Husain K. Interaction of exercise training and chronic ethanol ingestion on antioxidant system of rat brain regions. J Appl Toxicol. 1997;17:329-336.
15. 99mTc]-d,l-HM-PAO in rat brain: an autoradiographic study. J Cereb Blood Flow Metab. 1988;8:S38-S43.
16. Roth CA, Hoffman TJ, Corlija M, et al. The effect of ligand structure on glutathione-mediated decomposition of propylene amine oxime derivatives. Nucl Med Biol. 1992;19:783-790.
17. Hjelle OP, Chaudhry FA, Ottersen OP. Antisera to glutathione: characterization and immunocytochemical application to the rat cerebellum. Eur J Neurosci. 1994;6:793-804.
18. Pringle AK, Iannotti F, Wilde GJC, et al. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Brain Res. 1997;755: 36-46.
19. Kato H, Kogure K, Arakai T, et al. Immunohistochemical localization of Superoxide dismutase in the hippocampus following ischemia in a gerbil model of tolerance. J Cereb Blood Flow Metab. 1995;15:60-70.
20. Uz T, Giusti P, Franceschini D, et al. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neurosci. 1996;7:631-636.
21. Wilde GJC, Pringle AK, Wright P, et al. Differential vulnerability of the CA1 and CA3 subfields of the hippocampus to Superoxide and hydroxyl radicals in vitro. J Neurochem. 1997;69:883-886.